DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Double Patenting
The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969).
A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b).
The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13.
The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer.
Claims 52, 55-56, 58-66, 68-78 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-32 of U.S. Patent No. 12268552. Although the claims at issue are not identical, they are not patentably distinct from each other because:
19075579
US12268552
52. A method for guiding ultrasound acquisition in an individual, the method comprising:
1 and 23. A method for detecting a presence of an atheroma using an ultrasound apparatus, the method comprising:
obtaining echo signals produced in response to generated ultrasound signals;
repeatedly obtaining echo signals produced in response to ultrasound signals generated via a transducer;
producing ultrasound image data based on the obtained echo signals;
based on the obtained echo signals, producing ultrasound image data via processing circuitry;
detecting one or more blood vessels from the ultrasound image data;
detecting, via the processing circuitry and without user input, a volume of interest and one or more blood vessels from the ultrasound image data in a target region of a patient's body as the echo signals are being obtained;
identifying an artery from the one or more blood vessels as the echo signals are being obtained, wherein the artery includes at least a segment of a common region and a bifurcated region of the artery, and wherein identifying the artery is based on:
(i) a brightness of a wall of the artery,
(ii) a darkness in a lumen of the artery, and
(iii) a difference between the brightness of the artery wall and the darkness of the artery lumen;
identifying, via the processing circuitry and from the one or more blood vessels, an artery of interest based on:
a brightness of a wall of the artery of interest,
a darkness in a lumen of the artery of interest, and
a difference between the brightness of the artery wall and the darkness of the artery lumen; […]wherein a tracked length of the artery of interest encompasses at least a segment of a common carotid region of the carotid artery of the patient and a bifurcated region of the carotid artery;
determining (i) an edge of a first peak of a first echo signal corresponding to a media-adventitia boundary (MAB) and (ii) an edge of a second peak of a second echo signal corresponding to lumen-intima boundary (LIB); and
obtaining a plurality of intima-media thicknesses (IMTs) along a longitudinal axis of the artery of interest, wherein each of the IMTs is based on a distance between edges of (i) a first peak of a first echo signal corresponding to a media-adventitia boundary and (ii) a second peak corresponding to a lumen-intima boundary;
calculating, based on the MAB and the LIB, at least one of (i) an intima-media thickness (IMT) along the artery, (ii) an intima-media area (IMA) at one or more locations of the artery, or (iii) an intima-media volume (IMV) over a predetermined length of the artery.
based at least in part on the obtained IMTs, calculating, via the processing circuitry, a first cross-sectional intima-media area (IMA) of the artery of interest at a first location along a length of the artery of interest;
based at least in part on the obtained IMTs, calculating, via the processing circuitry, a second IMA of the artery of interest at a second or more locations along the length of the artery of interest; and
based at least in part on the calculations of the first and second IMAs of the artery of interest, calculating, via the processing circuitry, an intima-media volume (IMV), arterial volume, and luminal volume of the artery of interest over a predetermined length of the artery of interest.
53. The method of claim 52, wherein the IMT along the artery is along a radial direction of the artery.
N/A
54. The method of claim 52, further comprising identifying a focally elevated IMT of the artery based on at least one of (i) the IMT along the artery, (ii) the IMA at the one or more locations of the artery, or (iii) the IMV over the predetermined length of the artery.
N/A
55. The method of claim 52, wherein calculating the IMT along the artery comprises calculating a distance between the MAB and the LIB.
obtaining a plurality of intima-media thicknesses (IMTs) along a longitudinal axis of the artery of interest, wherein each of the IMTs is based on a distance between edges of (i) a first peak of a first echo signal corresponding to a media-adventitia boundary and (ii) a second peak corresponding to a lumen-intima boundary;
56. The method of claim 52, wherein calculating the IMA at the one or more locations of the artery comprises calculating a plurality of IMTs along the artery.
obtaining a plurality of intima-media thicknesses (IMTs) along a longitudinal axis of the artery of interest, wherein each of the IMTs is based on a distance between edges of (i) a first peak of a first echo signal corresponding to a media-adventitia boundary and (ii) a second peak corresponding to a lumen-intima boundary;
57. The method of claim 52, further comprising identifying a narrowing along the artery based on the IMA at the one or more locations of the artery.
N/A
58. The method of claim 52, wherein calculating the IMV over the predetermined length of the artery comprises calculating a first IMA at a first location of the artery and a second IMA at a second location of the artery different than the first location.
based at least in part on the obtained IMTs, calculating, via the processing circuitry, a first cross-sectional intima-media area (IMA) of the artery of interest at a first location along a length of the artery of interest;
based at least in part on the obtained IMTs, calculating, via the processing circuitry, a second IMA of the artery of interest at a second or more locations along the length of the artery of interest; and
59. The method of claim 52, wherein identifying the artery from the one or more blood vessels occurs at a first time and a second time after the first time, and wherein the method further comprises calculating a difference in IMV by:
calculating a first IMV over the predetermined length of the artery identified at the first time; and
calculating a second IMV over the predetermined length of the artery identified at the second time.
based at least in part on the calculations of the first and second IMAs of the artery of interest, calculating, via the processing circuitry, an intima-media volume (IMV), arterial volume, and luminal volume of the artery of interest over a predetermined length of the artery of interest.
24. […] wherein identifying the artery of interest occurs at a first time and wherein the IMV is a first IMV, the method further comprising:
identifying the artery of interest from the one or blood vessels at a second time after the first time;
obtaining a third IMA of the artery of interest at a third location of the artery of interest;
obtaining a fourth IMA of the artery of interest at a fourth location different than the third location; and
based at least in part on the third IMA and the fourth IMA, obtaining a second IMV of the artery of interest over a predetermined length of the artery of interest; and
comparing the first IMV with the second IMV to determine progression or regression of atherosclerosis.
60. The method of claim 59, wherein calculating the first IMV over the predetermined length of the artery comprises calculating a first IMA at a first location of the artery and a second IMA at a second location of the artery different than the first location, and wherein calculating the second IMV over the predetermined length of the artery comprises calculating a third IMA at a third location of the artery and a fourth IMA at a fourth location of the artery different than the third location.
24. […] wherein identifying the artery of interest occurs at a first time and wherein the IMV is a first IMV, the method further comprising:
identifying the artery of interest from the one or blood vessels at a second time after the first time;
obtaining a third IMA of the artery of interest at a third location of the artery of interest;
obtaining a fourth IMA of the artery of interest at a fourth location different than the third location; and
based at least in part on the third IMA and the fourth IMA, obtaining a second IMV of the artery of interest over a predetermined length of the artery of interest; and
comparing the first IMV with the second IMV to determine progression or regression of atherosclerosis.
61. The method of claim 52, further comprising detecting physiological changes associated with a cardiac cycle of the individual, and wherein calculating at least one of the IMT, the IMA, or the IMV is based at least in part on the physiological changes associated with the cardiac cycle of the individual.
25. The method of claim 23, further comprising detecting physiological changes associated with the cardiac cycle of the patient, wherein obtaining the first IMA and/or obtaining the second IMA is based at least in part on the detected physiological changes associated with the cardiac cycle of the patient.
62. The method of claim 52, wherein identifying the artery from the one or more blood vessels comprises (i) creating a 3-dimensional (3D) dataset of the one or more blood vessels using radio frequency (RF) correlation, and (ii) creating 2-dimensional (2D) frames out of the 3D dataset, wherein the 2D frames include at least a first frame, a second frame, and a third frame, and wherein the method further comprises determining, via cross-correlation of the first frame to the second frame, the first frame to the third frame, and the second frame to the third frame, that each of the first frame, the second frame, and the third frame include the artery.
identifying, without user input and via the processing circuitry, an artery of interest from the one or more blood vessels as the echo signals are being obtained by (i) creating a 3D dataset of the one or more blood vessels using radio frequency (RF) correlation, and (ii) creating virtual 2-dimensional (2D) frames out of the 3D dataset, wherein the 2D frames include at least a first frame, a second frame, and a third frame, and wherein the artery of interest includes at least two of (i) a bulb of the carotid artery of the patient, (ii) a bifurcation of the carotid artery, or (iii) a common carotid region of the carotid artery, wherein identifying the artery of interest is based on (i) a brightness of a wall of the artery, (ii) a darkness in a lumen of the artery, and (iii) a difference between the brightness of the artery wall and the darkness of the artery lumen;
63. The method of claim 52, wherein detecting the one or more blood vessels from the ultrasound image data comprises utilizing a machine learning method of a neural network trained to identify blood vessels in ultrasound echography images by using self-derived features and standard vessel characteristics.
5. The method of claim 1, wherein identifying the artery of interest comprises utilizing a machine learning method of neural network trained to identify vessels in ultrasound echography images by using self-derived features and standard vessel characteristics.
64. The method of claim 52, wherein detecting the one or more blood vessels from the ultrasound image data comprises identifying blood flow data as represented by a color map of Doppler signal analysis.
8. The method of claim 1, wherein detecting the one or more blood vessels comprises identifying, via the processor, blood flow data as represented by a color map of Doppler signal analysis.
65. The method of claim 52, wherein identifying the artery from the one or more blood vessels comprises utilizing a machine learning method of a neural network trained to identify blood vessels in ultrasound echography images by using self-derived features and standard vessel characteristics.
5. The method of claim 1, wherein identifying the artery of interest comprises utilizing a machine learning method of neural network trained to identify vessels in ultrasound echography images by using self-derived features and standard vessel characteristics.
66. An ultrasound system configured to guide ultrasound acquisition in an individual, comprising:
1. A method for detecting a presence of an atheroma using an ultrasound apparatus, the method comprising:
a transducer configured to obtain echo signals produced in response to generated ultrasound signals; and
repeatedly obtaining echo signals produced in response to ultrasound signals generated via a transducer;
processing circuitry operably coupled to the transducer and configured to execute program instructions to:
based on the obtained echo signals, producing ultrasound image data via processing circuitry;
produce ultrasound image data based on the obtained echo signals;
detecting, via the processing circuitry and without user input, a volume of interest and one or more blood vessels from the ultrasound image data in a target region of a patient's body as the echo signals are being obtained;
detect one or more blood vessels from the ultrasound image data; identify an artery from the one or more blood vessels as the echo signals are being obtained, wherein the artery includes at least a segment of a common region and a bifurcated region of the artery, and wherein identifying the artery is based on:
(i) a brightness of a wall of the artery,
(ii) a darkness in a lumen of the artery, and
(iii) a difference between the brightness of the artery wall and the darkness of the artery lumen;
identifying, via the processing circuitry and from the one or more blood vessels, an artery of interest based on:
a brightness of a wall of the artery of interest,
a darkness in a lumen of the artery of interest, and
a difference between the brightness of the artery wall and the darkness of the artery lumen; […]wherein a tracked length of the artery of interest encompasses at least a segment of a common carotid region of the carotid artery of the patient and a bifurcated region of the carotid artery;
determine (i) an edge of a first peak of a first echo signal corresponding to a media-adventitia boundary (MAB) and (ii) an edge of a second peak of a second echo signal corresponding to lumen-intima boundary (LIB); and
obtaining a plurality of intima-media thicknesses (IMTs) along a longitudinal axis of the artery of interest, wherein each of the IMTs is based on a distance between edges of (i) a first peak of a first echo signal corresponding to a media-adventitia boundary and (ii) a second peak corresponding to a lumen-intima boundary;
calculate, based on the MAB and the LIB, at least one of (i) an intima-media thickness (IMT) along the artery, (ii) an intima-media area (IMA) at one or more locations of the artery, or (iii) an intima-media volume (IMV) over a predetermined length of the artery.
based at least in part on the obtained IMTs, calculating, via the processing circuitry, a first cross-sectional intima-media area (IMA) of the artery of interest at a first location along a length of the artery of interest;
based at least in part on the obtained IMTs, calculating, via the processing circuitry, a second IMA of the artery of interest at a second or more locations along the length of the artery of interest; and
based at least in part on the calculations of the first and second IMAs of the artery of interest, calculating, via the processing circuitry, an intima-media volume (IMV), arterial volume, and luminal volume of the artery of interest over a predetermined length of the artery of interest.
67. The ultrasound system of claim 66, wherein the processing circuitry is configured to execute instructions to identify a focally elevated IMT of the artery based on at least one of (i) the IMT along the artery, (ii) the IMA at the one or more locations of the artery, or (iii) the IMV over the predetermined length of the artery.
N/A
68. The ultrasound system of claim 66, wherein calculating the IMT along the artery comprises calculating a distance between the MAB and the LIB.
obtaining a plurality of intima-media thicknesses (IMTs) along a longitudinal axis of the artery of interest, wherein each of the IMTs is based on a distance between edges of (i) a first peak of a first echo signal corresponding to a media-adventitia boundary and (ii) a second peak corresponding to a lumen-intima boundary;
69. The ultrasound system of claim 66, wherein calculating the IMA at the one or more locations of the artery comprises calculating a plurality of IMTs along the artery.
obtaining a plurality of intima-media thicknesses (IMTs) along a longitudinal axis of the artery of interest, wherein each of the IMTs is based on a distance between edges of (i) a first peak of a first echo signal corresponding to a media-adventitia boundary and (ii) a second peak corresponding to a lumen-intima boundary;
70. The ultrasound system of claim 66, wherein calculating the IMV over the predetermined length of the artery further comprises calculating a first IMA at a first location of the artery and a second IMA at a second location of the artery different than the first location.
based at least in part on the obtained IMTs, calculating, via the processing circuitry, a first cross-sectional intima-media area (IMA) of the artery of interest at a first location along a length of the artery of interest;
based at least in part on the obtained IMTs, calculating, via the processing circuitry, a second IMA of the artery of interest at a second or more locations along the length of the artery of interest; and
71. The ultrasound system of claim 66, wherein identifying the artery from the one or more blood vessels occurs at a first time and a second time after the first time, and wherein the method further comprises calculating a difference in the IMV by calculating (i) a first IMV over the predetermined length of the artery identified at the first time and (ii) a second IMV over the predetermined length of the artery identified at the second time.
based at least in part on the calculations of the first and second IMAs of the artery of interest, calculating, via the processing circuitry, an intima-media volume (IMV), arterial volume, and luminal volume of the artery of interest over a predetermined length of the artery of interest.
24. […] wherein identifying the artery of interest occurs at a first time and wherein the IMV is a first IMV, the method further comprising:
identifying the artery of interest from the one or blood vessels at a second time after the first time;
obtaining a third IMA of the artery of interest at a third location of the artery of interest;
obtaining a fourth IMA of the artery of interest at a fourth location different than the third location; and
based at least in part on the third IMA and the fourth IMA, obtaining a second IMV of the artery of interest over a predetermined length of the artery of interest; and
comparing the first IMV with the second IMV to determine progression or regression of atherosclerosis.
72. The ultrasound system of claim 71, wherein calculating the IMV comprises calculating (i) the first IMV by calculating a first IMA at a first location of the artery and a second IMA at a second location of the artery different than the first location and (ii) the second IMV by calculating a third IMA at a third location of the artery and a fourth IMA at a fourth location of the artery different than the third location.
24. […] wherein identifying the artery of interest occurs at a first time and wherein the IMV is a first IMV, the method further comprising:
identifying the artery of interest from the one or blood vessels at a second time after the first time;
obtaining a third IMA of the artery of interest at a third location of the artery of interest;
obtaining a fourth IMA of the artery of interest at a fourth location different than the third location; and
based at least in part on the third IMA and the fourth IMA, obtaining a second IMV of the artery of interest over a predetermined length of the artery of interest; and
comparing the first IMV with the second IMV to determine progression or regression of atherosclerosis.
73. The ultrasound system of claim 66, wherein the processing circuitry is configured to execute instructions to detect physiological changes associated with a cardiac cycle of the individual, and wherein calculating is based at least in part on the physiological changes associated with the cardiac cycle of the individual.
25. The method of claim 23, further comprising detecting physiological changes associated with the cardiac cycle of the patient, wherein obtaining the first IMA and/or obtaining the second IMA is based at least in part on the detected physiological changes associated with the cardiac cycle of the patient.
74. The ultrasound system of claim 66, wherein identifying the artery from the one or more blood vessels comprises (i) creating a 3-dimensional (3D) dataset of the one or more blood vessels using radio frequency (RF) correlation, and (ii) creating 2-dimensional (2D) frames out of the 3D dataset, wherein the 2D frames include at least a first frame, a second frame, and a third frame, and wherein the processing circuitry is configured to execute instructions to determine, via cross-correlation of the first frame to the second frame, the first frame to the third frame, and the second frame to the third frame, that each of the first frame, the second frame, and the third frame include the artery.
identifying, without user input and via the processing circuitry, an artery of interest from the one or more blood vessels as the echo signals are being obtained by (i) creating a 3D dataset of the one or more blood vessels using radio frequency (RF) correlation, and (ii) creating virtual 2-dimensional (2D) frames out of the 3D dataset, wherein the 2D frames include at least a first frame, a second frame, and a third frame, and wherein the artery of interest includes at least two of (i) a bulb of the carotid artery of the patient, (ii) a bifurcation of the carotid artery, or (iii) a common carotid region of the carotid artery, wherein identifying the artery of interest is based on (i) a brightness of a wall of the artery, (ii) a darkness in a lumen of the artery, and (iii) a difference between the brightness of the artery wall and the darkness of the artery lumen;
75. The ultrasound system of claim 66, wherein detecting the one or more blood vessels from the ultrasound image data comprises utilizing a machine learning method of a neural network trained to identify blood vessels in ultrasound echography images by using self-derived features and standard vessel characteristics.
5. The method of claim 1, wherein identifying the artery of interest comprises utilizing a machine learning method of neural network trained to identify vessels in ultrasound echography images by using self-derived features and standard vessel characteristics.
76. The ultrasound system of claim 66, wherein detecting the one or more blood vessels from the ultrasound image data comprises identifying blood flow data as represented by a color map of Doppler signal analysis.
8. The method of claim 1, wherein detecting the one or more blood vessels comprises identifying, via the processor, blood flow data as represented by a color map of Doppler signal analysis.
77. The ultrasound system of claim 66, wherein identifying the artery from the one or more blood vessels comprises utilizing a machine learning method of a neural network trained to identify blood vessels in ultrasound echography images by using self-derived features and standard vessel characteristics.
5. The method of claim 1, wherein identifying the artery of interest comprises utilizing a machine learning method of neural network trained to identify vessels in ultrasound echography images by using self-derived features and standard vessel characteristics.
78. A method for guiding ultrasound acquisition in an individual, the method comprising:
1. A method for detecting a presence of an atheroma using an ultrasound apparatus, the method comprising:
directing ultrasound signals towards a target region of the individual;
repeatedly obtaining echo signals produced in response to ultrasound signals generated via a transducer;
obtaining corresponding echo signals from the target region;
based on the obtained echo signals, producing ultrasound image data via processing circuitry;
producing ultrasound image data from the obtained echo signals;
detecting, via the processing circuitry and without user input, a volume of interest and one or more blood vessels from the ultrasound image data in a target region of a patient's body as the echo signals are being obtained;
detecting one or more blood vessels from the ultrasound image data;
identifying an artery from the one or more blood vessels as the echo signals are being obtained, wherein the artery includes at least a segment of a common region and a bifurcated region of the artery, and wherein identifying the artery is based on:
(i) a brightness of a wall of the artery,
(ii) a darkness in a lumen of the artery, and
(iii) a difference between the brightness of the artery wall and the darkness of the artery lumen;
identifying, via the processing circuitry and from the one or more blood vessels, an artery of interest based on:
a brightness of a wall of the artery of interest,
a darkness in a lumen of the artery of interest, and
a difference between the brightness of the artery wall and the darkness of the artery lumen; […]wherein a tracked length of the artery of interest encompasses at least a segment of a common carotid region of the carotid artery of the patient and a bifurcated region of the carotid artery;
determining (i) an edge of a first peak of a first echo signal corresponding to a media-adventitia boundary (MAB) and (ii) an edge of a second peak of a second echo signal corresponding to lumen-intima boundary (LIB); and
obtaining a plurality of intima-media thicknesses (IMTs) along a longitudinal axis of the artery of interest, wherein each of the IMTs is based on a distance between edges of (i) a first peak of a first echo signal corresponding to a media-adventitia boundary and (ii) a second peak corresponding to a lumen-intima boundary;
calculating, based on the MAB and the LIB, at least one of (i) an intima-media thickness (IMT) along the artery, (ii) an intima-media area (IMA) at one or more locations of the artery, or (iii) an intima-media volume (IMV) over a predetermined length of the artery.
based at least in part on the obtained IMTs, calculating, via the processing circuitry, a first cross-sectional intima-media area (IMA) of the artery of interest at a first location along a length of the artery of interest;
based at least in part on the obtained IMTs, calculating, via the processing circuitry, a second IMA of the artery of interest at a second or more locations along the length of the artery of interest; and
based at least in part on the calculations of the first and second IMAs of the artery of interest, calculating, via the processing circuitry, an intima-media volume (IMV), arterial volume, and luminal volume of the artery of interest over a predetermined length of the artery of interest.
Claim Rejections - 35 USC § 101
35 U.S.C. 101 reads as follows:
Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title.
Claims 52-78 are rejected under 35 U.S.C. 101 because the claimed invention is directed to a mental process type abstract idea without significantly more.
Regarding claim 1, claim 1 recites the steps “detecting… one or more blood vessels… identifying… an artery of interest…” which amount to nothing more than a person mentally selecting an artery and identifying an atheroma after viewing an ultrasound image based on brightness. The steps of “determining an edge of a first peak … and … an edge of a second peak” amount to nothing more than a person mentally observing a graph of an ultrasound signal aimed at a blood vessel to determine an MAB and LIB. The steps of “calculating… an IMT… calculating… an IMA… and calculating… an IMV” amount to nothing more than a person mentally observing the cross-sectional intima-media area of the artery and using the areas to determine volumes over the length of the observed artery. These steps, under their broadest reasonable interpretation, appear to recite a mental-process type abstract idea because they can be practically performed in the human mind or with the aid of pen and/or paper.
In claims 52, 66 ,and 78, the abstract idea judicial exception is not integrated into a practical application. In particular, claims recites the additional elements of “an ultrasound apparatus” and “processing circuity” to perform the abstract idea. However, the ultrasound apparatus is recited a high-level of generality (i.e. any generic ultrasound imaging apparatus) and amounts to no more than a mere insignificant pre-solution activity of data gathering. Similarly, the processor is also recited at a high-level of generality and amounts to nothing more than parts of a generic computer. Merely including instructions to implement an abstract idea does not integrate a judicial exception into practical application. See MPEP 2106.05f. Accordingly, the recited additional elements do not appear to, either individually or as a whole, integrate the judicial exception into a practical application, therefore claims 52, 66, and 78 are directed to a judicial exception.
Claims 52, 66, and 78 do not appear to include additional elements that are sufficient to amount to significantly more than the judicial exception. As discussed above with respect to integration of the abstract idea into a practical application, the additional element of an ultrasound apparatus amounts to no more than a mere insignificant pre-solution activity of data gathering and the processing circuitry appears to amount to no more than a generic computer used to implement an abstract idea of performing measurements. Accordingly, claims 52, 66, and 78 do not appear to confer an inventive concept that is significantly more than the judicial exception.
Regarding claims 53-61, 64, 67-73, and 76, these claims appear to only recite additional details of the abstract idea, specifying details about IMT calculation, IMA calculation, IMV calculation, or blood flow identification. These steps, under their broadest reasonable interpretation, appear to recite a mental-process type abstract idea because they can practically be performed in the human mind or with the aid of pen and/or paper.
Regarding claims 62 and 74, these claims recite limitations related to creating a 3D data set. These elements are insufficient to amount to “significantly more” than the abstract idea because they amount to no more than mere extra-solution activity of displaying data. Mere extra-solution activity does not integrate the judicial exception into a practical application nor does it add significantly more to the judicial exceptions.
Regarding claims 63, 65, 75, and 77, the claims merely recites further details related identifying using machine learning with a neural network. Machine learning with a neural network is also recited at a high-level of generality and amounts to nothing more than parts of a generic neural network. Merely including instructions to implement an abstract idea does not integrate a judicial exception into practical application. See MPEP 2106.05f. Accordingly, the recited additional elements do appear to, either individually or as a whole, integrated the judicial exception in a practical application nor do they appear to confer an inventive concept that is significantly more than the judicial exception.
Allowable Subject Matter
Claims 52-78 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 101, set forth in this Office action.
The following is a statement of reasons for the indication of allowable subject matter:
The prior art does not disclose nor reasonably suggest the limitations set forth in the independent claims. Specifically, the prior art does not disclose method for guiding ultrasound acquisition in an individual, the method comprising: obtaining echo signals produced in response to generated ultrasound signals; producing ultrasound image data based on the obtained echo signals; detecting one or more blood vessels from the ultrasound image data; identifying an artery from the one or more blood vessels as the echo signals are being obtained, wherein the artery includes at least a segment of a common region and a bifurcated region of the artery, and wherein identifying the artery is based on:(i) a brightness of a wall of the artery,(ii) a darkness in a lumen of the artery, and(iii) a difference between the brightness of the artery wall and the darkness of the artery lumen; determining (i) an edge of a first peak of a first echo signal corresponding to a media- adventitia boundary (MAB) and (ii) an edge of a second peak of a second echo signal corresponding to lumen-intima boundary (LIB); and calculating, based on the MAB and the LIB, at least one of (i) an intima-media thickness (IMT) along the artery, (ii) an intima-media area (IMA) at one or more locations of the artery, or (iii) an intima-media volume (IMV) over a predetermined length of the artery as set forth in the independent claims and in view of US12268552.
Conclusion
The prior art made of record and not relied upon is considered pertinent to applicant's disclosure.
US20140081142A1 – discloses limitations related to using ultrasound to measuring IMA, IMV and IMT
US20200151872A1 – discloses limitations related to identifying an artery based on brightness and darkness
F. Molinari et al, "Automated carotid IMT measurement and its validation in low contrast ultrasound database of patient indian population epidemiological study: results of AtheroEdge™ Software", Int'l Angiology, vol. 31, No. 1, pp. 1-22, Feb. 2012. – discloses limitations related to detecting the edges of a first peak of a first echo signal corresponding to a media-adventitia boundary and a second peak corresponding to a lumen-intima boundary
Any inquiry concerning this communication or earlier communications from the examiner should be directed to John Li whose telephone number is (313)446-4916. The examiner can normally be reached Monday to Thursday; 5:30 AM to 3:30 PM Eastern.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Pascal Bui-Pho can be reached on (571) 272-2714. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/JOHN D LI/Primary Examiner, Art Unit 3798